2seventy bio, Inc.
TSVT
$4.95
$0.255.32%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Revenue | -70.04% | -42.90% | 9.72% | 184.07% | 157.43% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -70.04% | -42.90% | 9.72% | 184.07% | 157.43% |
Cost of Revenue | -32.32% | -17.92% | -9.92% | -4.56% | -2.16% |
Gross Profit | -15.34% | -3.16% | 19.72% | 48.81% | 45.13% |
SG&A Expenses | -34.13% | -19.60% | -12.63% | -15.62% | -11.39% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -32.74% | -18.29% | -10.53% | -7.21% | -4.44% |
Operating Income | 4.57% | 4.59% | 17.57% | 39.51% | 35.20% |
Income Before Tax | 13.26% | -3.60% | 14.39% | 37.02% | 36.60% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 13.26% | -3.60% | 14.39% | 37.02% | 36.60% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 13.26% | -3.60% | 14.39% | 37.02% | 36.60% |
EBIT | 4.57% | 4.59% | 17.57% | 39.51% | 35.20% |
EBITDA | 5.00% | 4.76% | 17.88% | 40.15% | 35.01% |
EPS Basic | 28.72% | 20.41% | 41.77% | 59.03% | 58.75% |
Normalized Basic EPS | 22.99% | 30.44% | 47.12% | 63.31% | 58.79% |
EPS Diluted | 28.16% | 20.33% | 41.72% | 58.99% | 58.71% |
Normalized Diluted EPS | 23.36% | 30.44% | 47.12% | 63.31% | 58.79% |
Average Basic Shares Outstanding | 20.46% | 29.23% | 38.36% | 44.44% | 52.77% |
Average Diluted Shares Outstanding | 22.11% | 29.23% | 38.36% | 44.44% | 52.77% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |